Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ANDREW JARED PERANTEAU

Allopathic & Osteopathic Physicians Dermatology

NPI
1588075386
CMS profile
1120244
Location
NEW YORK, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$18,560.85

162 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 162 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ANDREW JARED PERANTEAU

NPI 1588075386 · CMS profile ID 1120244

Allopathic & Osteopathic Physicians / Dermatology

NEW YORK, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 162 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1588075386?year=2025&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ANDREW JARED PERANTEAU, NPI 1588075386, CMS profile ID 1120244. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 162 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1588075386?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). ANDREW JARED PERANTEAU, NPI 1588075386, CMS profile ID 1120244. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 162 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1588075386?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
ANDREW JARED PERANTEAU, NPI 1588075386, CMS profile ID 1120244, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 162 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1588075386?year=2025&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

162 matching records · $18,560.85 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 162 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 162.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novartis Pharmaceuticals Corporation $21.8704/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200630676 CMS
Janssen Biotech, Inc. $18.4704/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175420267 CMS
Regeneron Healthcare Solutions, Inc. $31.2604/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1213012104 CMS
ABBVIE INC. $21.5104/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203573384 CMS
Lilly USA, LLC $29.8404/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186507855 CMS
ABBVIE INC. $23.7404/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203573378 CMS
Incyte Corporation $8.2104/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226077439 CMS
ABBVIE INC. $19.9004/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203573374 CMS
E.R. Squibb & Sons, L.L.C. $25.6304/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184684624 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $11.0004/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250969448 CMS
Janssen Biotech, Inc. $24.2404/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175407400 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $17.5304/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250969466 CMS
UCB, Inc. $0.9104/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224386419 CMS
UCB, Inc. $25.4904/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224386421 CMS
ABBVIE INC. $2,275.0004/07/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1203573368 CMS
LEO Pharma Inc. $31.0904/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252028662 CMS
UCB, Inc. $13.0004/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224386417 CMS
Arcutis Biotherapeutics, Inc. $6.4904/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252327764 CMS
Arcutis Biotherapeutics, Inc. $15.2904/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252327766 CMS
E.R. Squibb & Sons, L.L.C. $16.4104/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184684622 CMS
Janssen Biotech, Inc. $33.3303/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175423283 CMS
Novartis Pharmaceuticals Corporation $15.1503/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200630672 CMS
Novartis Pharmaceuticals Corporation $0.5603/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200630674 CMS
Lilly USA, LLC $20.8903/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186481789 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $28.6103/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250969442 CMS
ABBVIE INC. $1.7703/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203573355 CMS
ABBVIE INC. $22.3403/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203573362 CMS
ABBVIE INC. $2,875.0003/14/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1203573351 CMS
Lilly USA, LLC $16.2103/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186505105 CMS
Novartis Pharmaceuticals Corporation $33.8203/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200630670 CMS
Lilly USA, LLC $24.7603/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186507853 CMS
ABBVIE INC. $1.4403/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203573339 CMS
ABBVIE INC. $11.9003/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203573345 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $29.0003/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250969444 CMS
E.R. Squibb & Sons, L.L.C. $21.2203/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184684592 CMS
LEO Pharma Inc. $19.3403/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252028660 CMS
Lilly USA, LLC $17.2502/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186472903 CMS
Regeneron Healthcare Solutions, Inc. $135.0002/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1213012102 CMS
Incyte Corporation $25.7902/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226045702 CMS
ABBVIE INC. $20.2002/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203573333 CMS
Lilly USA, LLC $25.7402/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186512597 CMS
Novartis Pharmaceuticals Corporation $30.1102/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200630668 CMS
Galderma Laboratories, L.P. $23.3802/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234689383 CMS
Janssen Biotech, Inc. $29.1602/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175439594 CMS
ABBVIE INC. $17.2702/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203573321 CMS
ABBVIE INC. $11.8202/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203573327 CMS
ABBVIE INC. $121.6102/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203573310 CMS
ABBVIE INC. $599.3202/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1203573317 CMS
UCB, Inc. $21.3102/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224386415 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $23.4502/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250969440 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $230.81 2
PY2020 $197.84 10
PY2021 $1,166.40 54
PY2022 $2,068.69 78
PY2023 $2,469.32 99
PY2024 $5,845.40 95
PY2025 $18,560.85 162

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $17,157.27 9
PY2024 Principal investigator $160,176.96 33
PY2023 Principal investigator $180,924.90 92
PY2022 Principal investigator $202,218.41 64
PY2021 Principal investigator $155,045.79 84
PY2020 Principal investigator $112.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

9 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $8,133.00 10/09/2025 Non-covered Recipient Entity
BOBBY BUKA MD PROFESSIONAL
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1202514227
Principal investigator 1 Incyte Corporation $45.00 06/01/2025 Non-covered Recipient Entity
THE DERMATOLOGY SPECIALISTS GREENWICH
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo No dispute reported 06/30/2026 1240601480
Principal investigator 1 PFIZER INC. $2,695.00 05/30/2025 Non-covered Recipient Entity
Bobby Buka MD PC
A PHASE 2 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF PF07275315 AND PF07264660 IN ADULT PARTICIPANTS WITH MODERATESEVERE ATOPIC DERMATITIS No dispute reported 06/30/2026 1228765583
Principal investigator 1 PFIZER INC. $139.80 05/29/2025 Non-covered Recipient Entity
Bobby Buka MD PC
A PHASE 2 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF PF07275315 AND PF07264660 IN ADULT PARTICIPANTS WITH MODERATESEVERE ATOPIC DERMATITIS No dispute reported 06/30/2026 1228763130
Principal investigator 1 PFIZER INC. $1,367.16 05/06/2025 Non-covered Recipient Entity
Bobby Buka MD PC
A PHASE 2 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF PF07275315 AND PF07264660 IN ADULT PARTICIPANTS WITH MODERATESEVERE ATOPIC DERMATITIS No dispute reported 06/30/2026 1228763905
Principal investigator 1 PFIZER INC. $79.20 03/22/2025 Non-covered Recipient Entity
Bobby Buka MD PC
A PHASE 2 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF PF07275315 AND PF07264660 IN ADULT PARTICIPANTS WITH MODERATESEVERE ATOPIC DERMATITIS No dispute reported 06/30/2026 1228779562
Principal investigator 1 PFIZER INC. $2,131.92 02/26/2025 Non-covered Recipient Entity
Bobby Buka MD PC
A PHASE 2 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF PF07275315 AND PF07264660 IN ADULT PARTICIPANTS WITH MODERATESEVERE ATOPIC DERMATITIS No dispute reported 06/30/2026 1228750621
Principal investigator 1 Incyte Corporation $481.55 02/12/2025 Non-covered Recipient Entity
THE DERMATOLOGY SPECIALISTS GREENWICH
A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Children (Ages 2 Years to 12 Years) With Atopic Dermatitis (TRuE-AD3) No dispute reported 06/30/2026 1240601476
Principal investigator 1 Incyte Corporation $2,084.64 01/23/2025 Non-covered Recipient Entity
THE DERMATOLOGY SPECIALISTS GREENWICH
A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Children (Ages 2 Years to 12 Years) With Atopic Dermatitis (TRuE-AD3) No dispute reported 06/30/2026 1240601471